Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions
In people with cholera, ORS ≤ 270 is associated with biochemical hyponatraemia when compared with ORS ≥ 310 [90 mmol/L of sodium, 20 mmol/L of potassium, 80 mmol/L of chloride, 10 mmol/L of citrate, and 111 mmol/L of glucose, with a total osmolarity of 311 mmol/L], but there are no differences in terms of other outcomes. Although this risk does not appear to be associated with any serious consequences, the total patient experience in existing trials is small. Under wider practice conditions, especially where patient monitoring is difficult, caution is warranted.
ORS is used to treat the dehydration caused by diarrhoeal diseases, including cholera. ORS formulations with an osmolarity (a measure of solute concentration) of ≤ 270 mOsm/L (ORS ≤ 270) are safe and more effective than ORS formulations with an osmolarity of ≥ 310 mOsm/L (ORS ≥ 310) for treating non-cholera diarrhoea. As cholera causes rapid electrolyte loss, it is important to know if these benefits are similar for people suffering from cholera. This review compares the safety and efficacy of ORS ≤270 with ORS ≥ 310 for treating dehydration due to cholera.
Adults, Both sexes (for groups of both male and female persons), Camp Coordination and Camp Management (CCCM), Child health, Children, Displaced population, Earthquake, Epidemic/Endemic, Flash flood/Flood, Gastrointestinal/Abdominal conditions, Genitourinary and gynaecologic conditions, Health, Heavy rain, Infections and infectious diseases (all), Malaria and protozoal infections, Neonates/infants, Population displacement, Vaccine-preventable infections, Zoonotic and other pathogens